These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4277691)

  • 21. Hyperuricosuric calcium oxalate nephrolithiasis.
    Coe FL
    Kidney Int; 1978 May; 13(5):418-26. PubMed ID: 661071
    [No Abstract]   [Full Text] [Related]  

  • 22. Calcium oxalate stone disease: effects and side effects of cellulose phosphate and succinate in long-term treatment of absorptive hypercalciuria or hyperoxaluria.
    Hautmann R; Hering FJ; Lutzeyer W
    J Urol; 1978 Dec; 120(6):712-5. PubMed ID: 731812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of uric acid in calcium-oxalate nephrolithiasis].
    Hartung R
    Fortschr Med; 1977 Jan; 95(2):67. PubMed ID: 832834
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcium oxalate crystalluria.
    Elliot JS; Rabinowitz IN; Silvert M
    J Urol; 1976 Dec; 116(6):773-5. PubMed ID: 12378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of diphosphonate on calcium phosphate crystallization in urine in vitro.
    Oata M; Pak CY
    Kidney Int; 1973 Dec; 4(6):401-6. PubMed ID: 4205283
    [No Abstract]   [Full Text] [Related]  

  • 26. Oxalate and renal stone formation.
    Tiselius HG
    Scand J Urol Nephrol Suppl; 1980; 53():135-48. PubMed ID: 6937989
    [No Abstract]   [Full Text] [Related]  

  • 27. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is matrix theory still important today?].
    Börner RH; Schneider HJ
    Z Urol Nephrol; 1982 Jun; 75(6):463-8. PubMed ID: 6812310
    [No Abstract]   [Full Text] [Related]  

  • 29. Diminished urinary excretion of cycle AMP by rats given disodium ethane-1-hydroxy-1,1-diphosphonate.
    Goulding A; McChesney R; Malthus RS
    J Endocrinol; 1975 Apr; 65(1):145-6. PubMed ID: 167091
    [No Abstract]   [Full Text] [Related]  

  • 30. Diphosphonate therapy in nephrocalcinosis.
    McCredie DA; Powell HR; Rotenberg E
    Br J Urol; 1976 Apr; 48(2):93-100. PubMed ID: 821572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystaloptical and spectroscopical findings with calcium oxalate crystals in the urine sediment: a contribution to the genesis of oxalate stones.
    Berg W; Schnapp JD; Schneider HJ; Hesse A; Hienzsch E
    Eur Urol; 1976; 2(2):92-7. PubMed ID: 971679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of calcium, oxalate and inhibitory activity of the urine in patients with calcium nephrolithiasis].
    Han KH; Cao LC; Ying YL
    Zhonghua Wai Ke Za Zhi; 1986 Mar; 24(3):173-5, 190. PubMed ID: 3757655
    [No Abstract]   [Full Text] [Related]  

  • 33. Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans.
    Baggio B; Gambaro G; Marchini F; Marzaro G; Williams HE; Borsatti A
    Lancet; 1991 Aug; 338(8764):403-5. PubMed ID: 1678082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial: Calcium nephrolithiasis and cellulose phosphate.
    Williams HE
    N Engl J Med; 1974 Jan; 290(4):224-5. PubMed ID: 4808920
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental and clinical studies on calcium urolithiasis: (I) Animal model for calcium oxalate urolithiasis using ethylene glycol and 1-alpha (OH) D3].
    Okada Y; Kawamura J; Nonomura M; Kuo YJ; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):565-77. PubMed ID: 4036734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Minar E
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanisms of renal lithogenesis. (VIII) Therapeutic response of hyperoxaluric patients after 5 years' treatment].
    Ruiz-Marcellán FJ; Bernshtam J; Pinto B
    Rev Clin Esp; 1983 Jan; 168(1):9-12. PubMed ID: 6844687
    [No Abstract]   [Full Text] [Related]  

  • 38. A contribution to the formation mechanism of calcium oxalate urinary calculi. I. Stabilising urinary constituents in the formation of weddellite.
    Hesse A; Berg W; Schneider HJ; Hienzsch E
    Urol Res; 1976 Nov; 4(3):125-8. PubMed ID: 1014173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary enzymes and calcium oxalate urolithiasis.
    Khan SR; Shevock PN; Hackett RL
    J Urol; 1989 Sep; 142(3):846-9. PubMed ID: 2570167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological rhythmicity and crystallization--urine profiles and Se-studies on calcium oxalate stone genesis.
    Berg W; Brundig P; Bothor C; Schneider HJ
    Int Urol Nephrol; 1982; 14(4):363-72. PubMed ID: 7182371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.